Bachem Holding AG

Price Chart

Risk-Adjusted Performance

Also Listed On

Bachem Holding AG (BANB) Price Performance

Bachem Holding AG (BANB) trades on SIX Swiss Exchange in CHF. The company is classified in the Basic Materials sector under the Chemicals industry. The stock currently trades at CHF62.65, up 1.29% from the previous close.

Over the past year, BANB has traded between a low of CHF44.03 and a high of CHF75.00. The stock has gained 17.8% over this period. It is currently 16.5% below its 52-week high.

Bachem Holding AG has a market capitalization of $4.52B, with a price-to-earnings ratio of 33.72 and a dividend yield of 1.44%.

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.